Drug targets for lymphatic filariasis: A bioinformatics approach

Journal of Vector Borne Diseases

Volumn 50, Issue 3, 2013, Pages 155-162

  Sharma, Om Prakash ^a   Vadlamudi, Yellamandaya ^a   Gupta Kota, Arun ^a   Kumar Sinha, Vikrant ^a   Suresh Kumar, Muthuvel ^a  

^a PONDICHERRY UNIVERSITY   (India)

Author keywords

Bioinformatics; Filariasis drug targets; Filariasis elimination programmes; Lymphatic filariasis; Proteomics and genomics

Indexed keywords

ADENOSYLMETHIONINE DECARBOXYLASE; ALBENDAZOLE; AMINE; AMINO ACID TRANSFER RNA LIGASE; BENZIMIDAZOLE; CHITIN; CYSTATHIONINE BETA SYNTHASE; DIETHYLCARBAMAZINE; DNA TOPOISOMERASE (ATP HYDROLYSING); FRUCTOSE BISPHOSPHATE ALDOLASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; ICOSANOID; IMIDAZOLE; IVERMECTIN; LEVAMISOLE; MEBENDAZOLE; OCTOPAMINE; PHOSPHOGLYCERATE MUTASE; PIPERAZINE; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROTEIN FARNESYLTRANSFERASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN N MYRISTOYLTRANSFERASE; RETINOL BINDING PROTEIN; TREHALOSE;

AEDES; ANOPHELES; BIOINFORMATICS; BRUGIA MALAYI; BRUGIA TIMORI; CULEX QUINQUEFASCIATUS; DISEASE TRANSMISSION; DRUG TARGETING; ERADICATION THERAPY; GENETIC VARIABILITY; HUMAN; LYMPHATIC FILARIASIS; LYMPHATIC SYSTEM; MORBIDITY; NONHUMAN; PATIENT COUNSELING; PATIENT EDUCATION; REVIEW; WUCHERERIA BANCROFTI;

ANIMALS; BRUGIA MALAYI; COMPUTATIONAL BIOLOGY; DRUG DISCOVERY; ELEPHANTIASIS, FILARIAL; FILARICIDES; GENOME, HELMINTH; HELMINTH PROTEINS; HUMANS; WUCHERERIA BANCROFTI;

EID: 84884749962     PISSN: 09729062     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Lipner EM, Law MA, Barnett E, Keystone JS, von Sonnenburg F, Loutan L, et al. Filariasis in travelers presenting to the GeoSentinel surveillance network. PLoS Negl Trop Dis 2007; 1: e88.
2. World Health Report 1995. Bridging the gaps. World Health Forum 1995; 16: 377-85.
3. Yeboah J, Afkhami M, Lee C, Sharma OP. Necrotizing sarcoid granulomatosis. Curr Opin Pulm Med 2012; 18: 493-8.
4. Shenoy RK. Lymphatic filariasis in children. J Commun Dis 2006; 38: 118-23.
5. Michael E, Bundy DA, Grenfell BT. Re-assessing the global prevalence and distribution of lymphatic filariasis. Parasitology 1996; 112 (4): 409-28.
6. Noordin R. Lymphatic filariasis and the global elimination program. Malays J Med Sci 2007; 14: 1-3.
7. Ottesen EA, Ismail MM, Horton J. The role of albendazole in programmes to eliminate lymphatic filariasis. Parasitol Today 1999; 15: 382-6.
8. Boakye DA, Baidoo HA, Glah E, Brown C, Appawu M, Wilson MD. Monitoring lymphatic filariasis interventions: Adult mosquito sampling and improved PCR-based pool screening method for Wuchereria bancrofti infection in Anopheles mosquitoes. Filaria J 2007; 6: 13.
9. Dreyer G, Coutinho A, Miranda D, Noroes J, Rizzo JA, Galdino E, et al. Treatment of bancroftian filariasis in Recife, Brazil: A two-year comparative study of the efficacy of single treatment with ivermectin or diethylcarbamazine. Trans R Soc Trop Med Hyg 1995; 89: 98-102.
10. Dreyer G, Addiss D, Williamson J, Noroes J. Efficacy of coadministered diethylcarbamazine and albendazole against adult Wuchereria bancrofti. Trans R Soc Trop Med Hyg 2006; 100: 1118-25.
11. Ramaiah KD, Das PK, Vanamail P, Pani SP. Impact of 10 years of diethylcarbamazine and ivermectin mass administration on infection and transmission of lymphatic filariasis. Trans R Soc Trop Med Hyg 2007; 101: 555-63.
12. Schwab AE, Boakye DA, Kyelem D, Prichard RK. Detection of benzimidazole resistance-associated mutations in the filarial nematode Wuchereria bancrofti and evidence for selection by albendazole and ivermectin combination treatment. Am J Trop Med Hyg 2005; 73: 234-8.
13. Sharma O, Pan A, Hoti SL, Jadhav A, Kannan M, Mathur P. Modeling, docking, simulation, and inhibitory activity of the benzimidazole analogue against β-tubulin protein from Brugia malayi for treating lymphatic filariasis. Med Chem Res 2012; 21: 2415-27.
14. Human filariasis: A global survey of epidemiology and control. In: Sasa M, editor. Baltimore: University Park Press 1976; p. vii, 819+3 leaves of plates.
15. Shenoy RK. Clinical and pathological aspects of filarial lymphedema and its management. Korean J Parasitol 2008; 46: 119-25.
16. Sabesan S, Ravi R, Das PK. Elimination of lymphatic filariasis in India. Lancet Infect Dis 2005; 5: 4-5.
17. Nandha B, Krishnamoorthy K. Impact of education campaign on community-based vector control in hastening the process of elimination of lymphatic filariasis in Tamil Nadu, South India. Health Educ Res 2012; 27: 585-94.
18. Ramu K, Ramaiah KD, Guyatt H, Evans D. Impact of lymphatic filariasis on the productivity of male weavers in a south Indian village. Trans R Soc Trop Med Hyg 1996; 90: 669-70.
19. Prospects of elimination of lymphatic filariasis in India. ICMR Bull 2012; 32 (5-6).
20. Uniting to combat neglected tropical diseases; Meeting report. Washington DC: World Bank 2012; p. 16.
21. Hogeweg P. The roots of bioinformatics in theoretical biology. PLoS Comput Biol 2011; 7: e1002021.
22. Addiss D. The VI meeting of the Global alliance to eliminate lymphatic filariasis: A half-time review of lymphatic filariasis elimination and its integration with the control of other neglected tropical diseases. Parasit Vectors 2010; 3: 100.
23. Casiraghi M, Anderson TJ, Bandi C, Bazzocchi C, Genchi C. A phylogenetic analysis of filarial nematodes: Comparison with the phylogeny of Wolbachia endosymbionts. Parasitology 2001; 122: 93-103.
24. Hoerauf A, Nissen-Pahle K, Schmetz C, Henkle-Duhrsen K, Blaxter ML, Buttner DW, et al. Tetracycline therapy targets intracellular bacteria in the filarial nematode Litomosoides sigmodontis and results in filarial infertility. J Clin Invest 1999; 103: 11-7.
25. Nuchprayoon S, Junpee A, Poovorawan Y. Random amplified polymorphic DNA (RAPD) for differentiation between Thai and Myanmar strains of Wuchereria bancrofti. Filaria J 2007; 6: 6.
26. Ghedin E, Wang S, Spiro D, Caler E, Zhao Q, Crabtree J, et al. Draft genome of the filarial nematode parasite Brugia malayi. Science 2007; 317: 1756-60.
27. Scott AL, Ghedin E, Nutman TB, McReynolds LA, Poole CB, Slatko BE, et al. Filarial and Wolbachia genomics. Parasit Immunol 2012; 34: 121-9.
28. Poole CB, Davis PJ, Jin J, McReynolds LA. Cloning and bioinformatic identification of small RNAs in the filarial nematode Brugia malayi. Mol Biochem Parasitol 2010; 169: 87-94.
29. Winter AD, Weir W, Hunt M, Berriman M, Gilleard JS, Devaney E. Diversity in parasitic nematode genomes: The microRNAs of Brugia pahangi and Haemonchus contortus are largely novel. BMC Genomics 2012; 13: 4.
30. Geldhof P, Murray L, Couthier A, Gilleard JS, McLauchlan G, Knox DP, et al. Testing the efficacy of RNA interference in Haemonchus contortus. Int J Parasitol 2006; 36: 801-10.
31. Issa Z, Grant WN, Stasiuk S, Shoemaker CB. Development of methods for RNA interference in the sheep gastrointestinal parasite Trichostrongylus colubriformis. Int J Parasitol 2005; 35: 935-40.
32. Anderson NL, Anderson NG. Proteome and proteomics: New technologies, new concepts, and new words. Electrophoresis 1998; 19: 1853-61.
33. Bennuru S, Meng Z, Ribeiro JM, Semnani RT, Ghedin E, Chan K, et al. Stage-specific proteomic expression patterns of the human filarial parasite Brugia malayi and its endosymbiont Wolbachia. Proc Nat Acad Sci USA 2011; 108: 9649-54.
34. Sharma OP, Jadhav A, Hussain A, Kumar MS. VPDB: Viral protein structural database. Bioinformation 2011; 6: 324-6.
35. Bhargavi R, Vishwakarma S, Murty US. Modeling analysis of GST (glutathione-s-transferases) from Wuchereria bancrofti and Brugia malayi. Bioinformation 2005; 1: 25-7.
36. Yadav M, Singh A, Rathaur S, Liebau E. Structural modeling and simulation studies of Brugia malayi glutathione-s-transferase with compounds exhibiting antifilarial activity: Implications in drug targeting and designing. J Mol Graph Model 2010; 28: 435-45.
37. Sharma OP, Vadlamudi Y, Liao Q, Strodel B, Suresh Kumar M. Molecular modeling, dynamics, and an insight into the structural inhibition of cofactor independent phosphoglycerate mutase isoform-1 from Wuchereria bancrofti using cheminformatics and mutational studies. J Biomol Struct Dyn 2013; 31 (7): 765-78.
38. Azeez S, Babu RO, Aykkal R, Narayanan R. Virtual screening and in vitro assay of potential drug like inhibitors from species against glutathione-s-transferase of filarial nematodes. J Mol Model 2012; 18: 151-63.
39. Acharya C, Coop A, Polli JE, Mackerell AD Jr. Recent advances in ligand-based drug design: Relevance and utility of the conformationally sampled pharmacophore approach. Curr Comput Aided Drug Des 2011; 7: 10-22.
40. Palayam M, Lakshminarayanan K, Radhakrishnan M, Krishnaswamy G. Preliminary analysis to target pyruvate phosphate dikinase from Wolbachia endosymbiont of Brugia malayi for designing antifilarial agents. Interdiscip Sci 2012; 4: 74-82.
41. Hedvat M, Emdad L, Das SK, Kim K, Dasgupta S, Thomas S, et al. Selected approaches for rational drug design and high throughput screening to identify anti-cancer molecules. Anticancer Agents Med Chem 2012; 9: 1143-55.
42. Segura-Cabrera A, Bocanegra-Garcia V, Lizarazo-Ortega C, Guo X, Correa-Basurto J, Rodriguez-Perez MA. A computational analysis of the binding mode of closantel as inhibitor of the Onchocerca volvulus chitinase: Insights on macrofilaricidal drug design. J Comput Aided Mol Des 2011; 25: 1107-19.
43. Garner AL, Gloeckner C, Tricoche N, Zakhari JS, Samje M, Cho-Ngwa F, et al. Design, synthesis and biological activities of closantel analogues: Structural promiscuity and its impact on Onchocerca volvulus. J Med Chem 2011; 54: 3963-72.
44. Lakshmi V, Joseph SK, Srivastava S, Verma SK, Sahoo MK, Dube V, et al. Antifilarial activity in vitro and in vivo of some flavonoids tested against Brugia malayi. Acta Trop 2010; 116: 127-33.
45. Anderson AC. The process of structure-based drug design. Chem Biol 2003; 10: 787-97.
46. Irwin JJ, Shoichet BK. ZINC: A free database of commercially available compounds for virtual screening. J Chem Inf Model 2005; 45: 177-82.
47. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, et al. DrugBank 3.0: A comprehensive resource for 'omics' research on drugs. Nucleic Acids Res 2011; 39: D1035-41.
48. Seiler KP, George GA, Happ MP, Bodycombe NE, Carrinski HA, Norton S. ChemBank: A small-molecule screening and cheminformatics resource database. Nucleic Acids Res 2008; 36: D351-9.
49. Li Q, Cheng T, Wang Y, Bryant SH. PubChem as a public resource for drug discovery. Drug Discov Today 2010; 15: 1052-7.
50. Allen FH, Taylor R. Research applications of the Cambridge structural database (CSD). Chem Soc Rev 2004; 33: 463-75.
51. von Grotthuss M, Koczyk G, Pas J, Wyrwicz LS, Rychlewski L. Ligand: Info small-molecule meta-database. Comb Chem High Throughput Screen 2004; 7: 757-61.
52. Jadhav A, Ezhilarasan V, Sharma OP, Pan A. Clostridium-DT(DB): A comprehensive database for potential drug targets of Clostridium difficile. Comput Biol Med 2013; 43: 362-7.
53. Magarinos MP, Carmona SJ, Crowther GJ, Ralph SA, Roos DS, Shanmugam D, et al. TDR targets: A chemogenomics resource for neglected diseases. Nucleic Acids Res 2012; 40: D1118-27.
54. Parkinson J, Whitton C, Schmid R, Thomson M, Blaxter M. NEMBASE: A resource for parasitic nematode ESTs. Nucleic Acids Res 2004; 32: D427-30.
55. Yook K, Harris TW, Bieri T, Cabunoc A, Chan J, Chen WJ, et al. WormBase 2012: More genomes, more data, new website. Nucleic Acids Res 2012; 40: D735-41.